Please use this identifier to cite or link to this item:
Title: Do clinical and experimental investigations support an antiatherogenic role for dietary phytosterols/stanols?
Authors: LOTTENBERG, Ana MariaBOMBO, Renata P. A.ILHA, AngelaNUNES, Valeria SuttiNAKANDAKARE, Edna R.QUINTAO, Eder C. R.
Citation: IUBMB LIFE, v.64, n.4, p.296-306, 2012
Abstract: The plasma cholesterol-reducing effect of phytosterols (PS) has been recognized in several studies, but the usefulness of PS in preventing coronary heart disease remains controversial, as some investigations claim that the high PS concentrations found in plasma and specific tissues are related to an increased risk of cardiovascular events. It has also been demonstrated that PS may induce inflammation and reduce cholesterol efflux from macrophages, conditions that are directly implicated in the development of atherosclerosis. As to arterial dysfunction and atherosclerosis, some studies have concluded that plasma PS concentrations are unrelated or only weakly related or that PS intake or plasma PS concentrations are harmful. Thus, in light of the National Cholesterol Education Program-ATPIII report, it is necessary to evaluate the relevance of their findings. To this end, we have evaluated the studies conducted on cells, animal models, and humans regarding the influence of PS on the development of atherosclerosis.
Appears in Collections:Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/10

Files in This Item:
File Description SizeFormat 
art_LOTTENBERG_Do_clinical_and_experimental_investigations_support_an_antiatherogenic_2012_eng.pdfpublishedVersion (English)906.25 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.